 Goldman Sachs Group Inc. boosted its stake in China Biologic Products Holdings Inc NASDAQ:CBPO by 154.2 in the fourth quarter, according to the company in its most recent 13F filing with the Securities Exchange Commission. The firm owned 119,316 shares of the biopharmaceutical companys stock after acquiring an additional 72,376 shares during the quarter. ... 